FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1607895158> ?p ?o ?g. }

• W1607895158 endingPage "416" @default.
• W1607895158 startingPage "406" @default.
• W1607895158 abstract "Daily efavirenz 400 mg (EFV400) was virologically noninferior to 600 mg (EFV600) at 48 weeks in treatment‐naïve patients. We evaluated EFV400 and EFV600 pharmacokinetics (NONMEM v. 7.2), assessing patient demographics and genetic polymorphisms ( CYP2B6, CYP2A6 , CYP3A4 , NR1I3 ) as covariates and explored relationships with efficacy (plasma HIV‐RNA (pVL) <200 copies/mL) and safety outcomes at 48 weeks in 606 randomized ENCORE1 patients (female = 32%, African = 37%, Asian = 33%; EFV400 = 311, EFV600 = 295). CYP2B6 516G>T/983T>C/ CYP2A6 *9B/*17 and weight were associated with efavirenz CL/F. Exposure was significantly lower for EFV400 (geometric mean ratio, GMR; 90% confidence interval, CI: 0.73 (0.68–0.78)) but 97% (EFV400) and 98% (EFV600) of evaluable pVL was <200 copies/mL at 48 weeks ( P = 0.802). Four of 20 patients with mid‐dose concentrations <1.0 mg/L had pVL ≥200 copies/mL (EFV400 = 1; EFV600 = 3). Efavirenz exposure was similar between those with and without efavirenz‐related side effects (GMR; 90% CI: 0.95 (0.88–1.02)). HIV suppression was comparable between doses despite significantly lower EFV400 exposure. Comprehensive evaluation of efavirenz pharmacokinetics/pharmacodynamics revealed important limitations in the accepted threshold concentration." @default.
• W1607895158 created "2016-06-24" @default.
• W1607895158 creator A5007876312 @default.
• W1607895158 creator A5011563703 @default.
• W1607895158 creator A5029267264 @default.
• W1607895158 creator A5030905646 @default.
• W1607895158 creator A5032374309 @default.
• W1607895158 creator A5035679710 @default.
• W1607895158 creator A5042249868 @default.
• W1607895158 creator A5058205661 @default.
• W1607895158 creator A5066429649 @default.
• W1607895158 creator A5067575028 @default.
• W1607895158 creator A5073732547 @default.
• W1607895158 creator A5073823420 @default.
• W1607895158 creator A5079967288 @default.
• W1607895158 creator A5081591095 @default.
• W1607895158 creator A5082394574 @default.
• W1607895158 creator A5089793108 @default.
• W1607895158 date "2015-07-14" @default.
• W1607895158 modified "2023-10-17" @default.
• W1607895158 title "Pharmacokinetic and Pharmacodynamic Comparison of Once‐Daily Efavirenz (400 mg vs. 600 mg) in Treatment‐Naïve HIV‐Infected Patients: Results of the ENCORE1 Study" @default.
• W1607895158 cites W1910280141 @default.
• W1607895158 cites W1992870356 @default.
• W1607895158 cites W1996214734 @default.
• W1607895158 cites W2003396355 @default.
• W1607895158 cites W2007253349 @default.
• W1607895158 cites W2011912864 @default.
• W1607895158 cites W2012459259 @default.
• W1607895158 cites W2034802701 @default.
• W1607895158 cites W2040151922 @default.
• W1607895158 cites W2045229224 @default.
• W1607895158 cites W2045503918 @default.
• W1607895158 cites W2046108896 @default.
• W1607895158 cites W2049761843 @default.
• W1607895158 cites W2050781209 @default.
• W1607895158 cites W2054323958 @default.
• W1607895158 cites W2058207881 @default.
• W1607895158 cites W2058952711 @default.
• W1607895158 cites W2059157689 @default.
• W1607895158 cites W2067172083 @default.
• W1607895158 cites W2070828622 @default.
• W1607895158 cites W2086199174 @default.
• W1607895158 cites W2090099730 @default.
• W1607895158 cites W2095442537 @default.
• W1607895158 cites W2099354741 @default.
• W1607895158 cites W2099746597 @default.
• W1607895158 cites W2106737113 @default.
• W1607895158 cites W2110868212 @default.
• W1607895158 cites W2110937893 @default.
• W1607895158 cites W2126853583 @default.
• W1607895158 cites W2131611794 @default.
• W1607895158 cites W2148524989 @default.
• W1607895158 cites W2164216849 @default.
• W1607895158 cites W2322399034 @default.
• W1607895158 doi "https://doi.org/10.1002/cpt.156" @default.
• W1607895158 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4744681" @default.
• W1607895158 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26044067" @default.
• W1607895158 hasPublicationYear "2015" @default.
• W1607895158 type Work @default.
• W1607895158 sameAs 1607895158 @default.
• W1607895158 citedByCount "65" @default.
• W1607895158 countsByYear W16078951582015 @default.
• W1607895158 countsByYear W16078951582016 @default.
• W1607895158 countsByYear W16078951582017 @default.
• W1607895158 countsByYear W16078951582018 @default.
• W1607895158 countsByYear W16078951582019 @default.
• W1607895158 countsByYear W16078951582020 @default.
• W1607895158 countsByYear W16078951582021 @default.
• W1607895158 countsByYear W16078951582022 @default.
• W1607895158 crossrefType "journal-article" @default.
• W1607895158 hasAuthorship W1607895158A5007876312 @default.
• W1607895158 hasAuthorship W1607895158A5011563703 @default.
• W1607895158 hasAuthorship W1607895158A5029267264 @default.
• W1607895158 hasAuthorship W1607895158A5030905646 @default.
• W1607895158 hasAuthorship W1607895158A5032374309 @default.
• W1607895158 hasAuthorship W1607895158A5035679710 @default.
• W1607895158 hasAuthorship W1607895158A5042249868 @default.
• W1607895158 hasAuthorship W1607895158A5058205661 @default.
• W1607895158 hasAuthorship W1607895158A5066429649 @default.
• W1607895158 hasAuthorship W1607895158A5067575028 @default.
• W1607895158 hasAuthorship W1607895158A5073732547 @default.
• W1607895158 hasAuthorship W1607895158A5073823420 @default.
• W1607895158 hasAuthorship W1607895158A5079967288 @default.
• W1607895158 hasAuthorship W1607895158A5081591095 @default.
• W1607895158 hasAuthorship W1607895158A5082394574 @default.
• W1607895158 hasAuthorship W1607895158A5089793108 @default.
• W1607895158 hasBestOaLocation W16078951581 @default.
• W1607895158 hasConcept C109650736 @default.
• W1607895158 hasConcept C111113717 @default.
• W1607895158 hasConcept C112705442 @default.
• W1607895158 hasConcept C126322002 @default.
• W1607895158 hasConcept C142462285 @default.
• W1607895158 hasConcept C159047783 @default.
• W1607895158 hasConcept C196013638 @default.
• W1607895158 hasConcept C2776239304 @default.
• W1607895158 hasConcept C2781432083 @default.
• W1607895158 hasConcept C2993143319 @default.
• W1607895158 hasConcept C3013748606 @default.

• next